People: Genomic Health Inc (GHDX.OQ)
23 Apr 2019
Dr. Fred E. Cohen, Ph.D. M.D., serves as Independent Director of the Company. Dr. Baker’s firm manages long-term investment funds, focused on publicly traded life sciences companies, for major university endowments and foundations. Dr. Baker’s career as a fund-manager began in 1994 when he and his brother co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker is also a director of Seattle Genetics, Inc., where he serves as lead independent director, and Alexion Pharmaceuticals, Inc. Dr. Baker served as a director of Synageva BioPharma Corp. from October 2000 until its acquisition in June 2015. Dr. Baker holds a B.S. and Ph.D. in Immunology from Stanford University, where he also completed two years of medical school.
|Total Annual Compensation, USD||15,250|
|Restricted Stock Awards, USD||40,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||132,727|
|Fiscal Year Total, USD||187,977|